Literature DB >> 3298601

Analysis of Toxocara canis larval excretory-secretory antigens: physicochemical characterization and antibody recognition.

J E Badley, R B Grieve, D D Bowman, L T Glickman, J H Rockey.   

Abstract

Toxocara canis larval excretory-secretory antigens (TEX) were resolved by gradient pore polyacrylamide gel electrophoresis and analyzed using silver, periodic acid-Schiff, and immunoperoxidase stains. At least 15 bands between 29 and 94 kilodaltons (kDa) were detected by silver stain, all of which were recognized by antibodies in serum of a patient with visceral larva migrans. Immunoperoxidase stain detected an additional band at 92 kDa and 4-6 others above 200 kDa. Periodic acid-Schiff stain also detected the high molecular weight components, but did not detect constituents of approximately 53 and 57 kDa. Immunoperoxidase stain using antibody from the vitreous fluid of an ocular larva migrans patient detected 2 TEX components, approximately 76 and 80 kDa. Antigens were compared with respect to batch of larvae and age of larvae in culture. Qualitative differences that correlated with batch were found in the number of constituents above 200 kDa, and in 1 component of 78 kDa. Qualitative differences were noted in many minor components, some of which appeared to correlate with age of larvae in culture. Major TEX constituents were recognized consistently by antibody, regardless of batch or age of larvae. Total protein production per larva was approximately 8 ng/day, and was consistent over time. There was no evidence of neutral proteases in TEX.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298601

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  9 in total

1.  A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay.

Authors:  Guita Rubinsky Elefant; Sumie Hoshino Shimizu; Maria Carmen Arroyo Sanchez; Cristina Miuki Abe Jacob; Antonio Walter Ferreira
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Identification of abundantly expressed novel and conserved genes from the infective larval stage of Toxocara canis by an expressed sequence tag strategy.

Authors:  K K Tetteh; A Loukas; C Tripp; R M Maizels
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis.

Authors:  H Yamasaki; K Araki; P K Lim; N Zasmy; J W Mak; R Taib; T Aoki
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  In vitro production of Toxocara canis excretory-secretory (TES) antigen.

Authors:  Divyamol Thomas; N Jeyathilakan; S Abdul Basith; T M A Senthilkumar
Journal:  J Parasit Dis       Date:  2014-12-20

5.  Characterization of excretory-secretory antigens of adult Toxocara canis by western blotting.

Authors:  N R Sudhakar; S Samanta; Shivani Sahu; O K Raina; S C Gupta; T K Goswami; K M Lokesh; Ashok Kumar
Journal:  J Parasit Dis       Date:  2012-11-29

6.  Application of the western blotting procedure for the immunodiagnosis of human toxocariasis.

Authors:  J F Magnaval; R Fabre; P Maurières; J P Charlet; B de Larrard
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

7.  Immunoregulatory Effects of Somatic Extract of Toxocara canis on Airway Inflammations in Murine Model.

Authors:  Milad Badri; Fatemeh Ghaffarifar; Zuhair M Hassan; Abdolhossein Dalimi; Hélder Cortes
Journal:  Iran J Parasitol       Date:  2020 Oct-Dec       Impact factor: 1.012

8.  Toxocara canis: molecular basis of immune recognition and evasion.

Authors:  Rick M Maizels
Journal:  Vet Parasitol       Date:  2012-12-20       Impact factor: 2.738

9.  Proteinases in excretory-secretory products of Toxocara canis second-stage larvae: zymography and modeling insights.

Authors:  Gonzalo Ernesto González-Páez; Fernando Alba-Hurtado; Carlos Gerardo García-Tovar; Raúl Argüello-García
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.